Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SHAREHOLDER ALERT: LPSN FULC BYND: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

LPSN, BYND, FULC

NEW YORK, NY / ACCESSWIRE / May 29, 2023 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

LivePerson, Inc. (NASDAQ: LPSN)

If you suffered a loss, contact us at:https://www.wongesq.com/pslra-1/liveperson-class-action-submission-form?prid=39979&wire=1
Lead Plaintiff Deadline: June 23, 2023
Class Period: May 10, 2022 - March 16, 2023

Allegations against LPSN include that: (1) LivePerson failed to address any material weaknesses with internal controls; (2) LivePerson's third quarter financial statements, ended in September 30, 2022 failed to disclose its subsidiary, WildHealth's, suspension of Medicare reimbursement; (3) as a result, LivePerson's fourth quarter 2022 revenue would be affected; and (4) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Fulcrum Therapeutics, Inc. (NASDAQ: FULC)

If you suffered a loss, contact us at:https://www.wongesq.com/pslra-1/fulcrum-class-action-submission-form?prid=39979&wire=1
Lead Plaintiff Deadline: June 27, 2023
Class Period: March 3, 2022 - March 8, 2023

Allegations against FULC include that: (i) the preclinical data submitted in support of FTX-6058 (an investigational oral fetal hemoglobin inducer for the treatment of sickle cell disease and other hemoglobinopathies) showed safety concerns regarding potential hematological malignancies; (ii) the foregoing safety concerns increased the likelihood that the FDA would place a clinical hold on preclinical studies of FTX-6058; (iii) accordingly, the Company had overstated FTX-6058's clinical and/or commercial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Beyond Meat, Inc. (NASDAQ: BYND)

If you suffered a loss, contact us at:https://www.wongesq.com/pslra-1/beyond-meat-class-action-submission-form?prid=39979&wire=1
Lead Plaintiff Deadline: July 10, 2023
Class Period: May 5, 2020 - October 13, 2022

According to the complaint, throughout the Class Period defendants made numerous materially false and misleading statements and omissions concerning the Company's ability to produce plant-based meats at scale. Specifically, defendants repeatedly assured investors that Beyond Meat conducted "extensive testing" to "ensure manufacturability" of its plant-based meat products at commercial scale, and touted the success of the Company's product tests with its large-scale partnerships as "very positive." Further, defendants blamed any delays in launching these large-scale partnerships on Covid-19.

The Law Offices of Vincent Wong, Monday, May 29, 2023, Press release picture

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE : The Law Offices of Vincent Wong



View source version on accesswire.com:
https://www.accesswire.com/757804/SHAREHOLDER-ALERT-LPSN-FULC-BYND-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today